ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)
CAPS Rating:
The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.
RSS Headlines
Fool UK
Recs
Article from Zacks Biotech Guy - Jason Napodano - trying a strategy where I set 10% stops on all these and let the winners run.